Tamara Langeberg Minneapolis Heart

Tamara Langeberg, BSN, MSN

Nurse Practitioner

Tamara Langeberg RN, MSN, CNP is credentialed through the ANCC (American Nurses Credentialing Center) as a family nurse practitioner. She completed her BSN (bachelor of science in nursing) in 1995, and MSN (Master of Science in nursing) in 2002 at Minnesota State University, Mankato. She has worked as a nurse practitioner with the Minneapolis Heart Institute since 2002, initially working with the general cardiology service, she has been with the electrophysiology group since 2004. As part of the Heart Rhythm Management Team, Tamara provides cardiac electrophysiology care for patients in the hospital and clinic setting, and performs direct current cardioversions, and tilt table studies. She has been instrumental in the development of the cardioversion program, as well as standardization of anticoagulation protocols.

Back to Heart Rhythm Team

Tamara Langeberg Minneapolis Heart
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.